Top compounds associated with response to FCRL2


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.00026 1
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.00024 1
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.00015 1
mRNA PD-0332991 FIMM pan-cancer AAC 0.00048 1
mRNA serdemetan FIMM pan-cancer AAC -0.00028 1
mRNA PD-0332991 CCLE pan-cancer AAC -3.6e-05 1
Download CSV